Drug Manufacturers say that Health Technology Assessment (HTA) agencies see a high price tag and are too quick to not recommend; HTA agencies argue that drug manufacturers are asking for increasingly higher prices that do not match the drug’s effectiveness. Will they ever see eye to eye? Take a look at Germany’s G-BA for more in sites, here. (Source: Context Matters, 12/5/14).
You are here: / / HTA Agencies & Manufacturers – Will They Ever See Eye To Eye?